A Science and Technology Blog
In all, 492 severe and serious AEFI have been classified by the AEFI Secretariat of the immunisation technical support unit (ITSU) at the Health Ministry. Classification has been completed for…
Names of the ten members Dr. Varsha Gupta, Professor, Department of Microbiology, Government Medical College Hospital, Chandigarh; 2) Dr. Archana Thakur, Medical Director, Professor and HOD (Microbiology), G.B. Pant Hospital,…
While it is unclear if pre-existing antibodies to adenovirus vector will affect vaccine efficacy, it is possible that repeated vaccination using adenovirus-based vaccine either as a booster or as annual vaccination, if the need arises, will result in reduced efficacy due to vector immunity.
The vaccine efficacy was measured based on symptomatic COVID-19 disease — mild, moderate or severe — two weeks after the second dose. The interim analysis undertaken at the first endpoint…
The results have been posted on medRxiv preprint server. Preprints are yet to be peer-reviewed and published in scientific journals. Though measurements were made only till day 28 after the…
“The list of comorbidities provided by the Health Ministry is overly restrictive and complicated. Many conditions, including obesity, have been left out,” says Dr. Gagandeep Kang, Professor of Microbiology at…
Roping in the private sector to support the government programme of vaccinating about 270 million people belonging to the two high-risk priority groups can surely speed up vaccination coverage. At…
Those older than 45 years and with comorbidities will need a certificate from a registered medical doctor. But those older than 60 years will not need any certificate. only Serum Institute’s Covishield vaccine will be available at private hospitals. Self-registration needed for those above 45 years with comorbidities.
